Published in J Vasc Interv Radiol on November 01, 2007
Interventional cardiovascular magnetic resonance: still tantalizing. J Cardiovasc Magn Reson (2008) 1.46
Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model. Radiology (2012) 0.75
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology (2009) 3.57
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology (2008) 3.52
Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project. Neuroimage (2013) 2.68
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35
Early neural responses to strength training. J Appl Physiol (1985) (2011) 1.74
Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol (2007) 1.73
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62
Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res (2010) 1.56
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology (2010) 1.55
Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation of reproducibility and age- and gender-dependence with fully automatic image postprocessing algorithm. Magn Reson Med (2007) 1.53
Automated rectilinear self-gated cardiac cine imaging. Magn Reson Med (2004) 1.52
Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol (2004) 1.48
Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol (2007) 1.45
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology (2008) 1.45
Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology (2009) 1.44
Primary failure of uterine artery embolization: use of magnetic resonance imaging to select patients for repeated embolization. J Vasc Interv Radiol (2005) 1.43
Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol (2009) 1.43
Cross education: possible mechanisms for the contralateral effects of unilateral resistance training. Sports Med (2007) 1.40
Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol (2008) 1.33
Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging. Radiology (2007) 1.32
Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med (2005) 1.32
Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol (2007) 1.31
90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg (2008) 1.30
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol (2008) 1.29
The ipsilateral motor cortex contributes to cross-limb transfer of performance gains after ballistic motor practice. J Physiol (2009) 1.27
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology (2011) 1.25
Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics (2008) 1.25
A dual-projection respiratory self-gating technique for whole-heart coronary MRA. J Magn Reson Imaging (2008) 1.24
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol (2007) 1.23
Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. J Vasc Interv Radiol (2003) 1.23
MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model. Radiology (2010) 1.22
Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology (2002) 1.21
Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol (2007) 1.20
Three-dimensional T2-weighted MRI of the human femoral arterial vessel wall at 3.0 Tesla. Invest Radiol (2009) 1.19
Muscle coordination is habitual rather than optimal. J Neurosci (2012) 1.19
Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol (2008) 1.19
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. Radiology (2008) 1.19
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer (2009) 1.19
Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol (2009) 1.18
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol (2009) 1.17
Are muscle synergies useful for neural control? Front Comput Neurosci (2013) 1.17
Aneurysms of the renal artery. Semin Vasc Surg (2005) 1.16
Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol (2004) 1.16
Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study. Radiology (2010) 1.16
Respiratory self-gated four-dimensional coronary MR angiography: a feasibility study. Magn Reson Med (2008) 1.15
Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol (2006) 1.15
Quantitative CBV measurement from static T1 changes in tissue and correction for intravascular water exchange. Magn Reson Med (2006) 1.14
Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer (2008) 1.14
Vertebral artery dissection: not a rare cause of stroke in the young. Age Ageing (2008) 1.14
Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats. Am J Transl Res (2010) 1.13
Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging (2005) 1.13
4D radial acquisition contrast-enhanced MR angiography and intracranial arteriovenous malformations: quickly approaching digital subtraction angiography. Stroke (2009) 1.12
Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol (2003) 1.12
Locomotor exercise induces long-lasting impairments in the capacity of the human motor cortex to voluntarily activate knee extensor muscles. J Appl Physiol (1985) (2008) 1.11
MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiology (2008) 1.11
Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors. J Vasc Interv Radiol (2007) 1.10
Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits. J Magn Reson Imaging (2008) 1.08
Real-time magnetic resonance imaging-guided coronary catheterization in swine. Circulation (2003) 1.08
Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol (2007) 1.07
Three-dimensional black-blood MR imaging of carotid arteries with segmented steady-state free precession: initial experience. Radiology (2007) 1.07
The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. J Vasc Interv Radiol (2009) 1.06
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol (2012) 1.06
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol (2008) 1.03
Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol (2008) 1.03
Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging (2013) 1.03
Secondary infections of thoracic and abdominal aortic endografts. J Vasc Interv Radiol (2008) 1.02
T2-prepared steady-state free precession blood oxygen level-dependent MR imaging of myocardial perfusion in a dog stenosis model. Radiology (2005) 1.02
Unilateral strength training increases voluntary activation of the opposite untrained limb. Clin Neurophysiol (2009) 1.02
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.02
Radial sliding-window magnetic resonance angiography (MRA) with highly-constrained projection reconstruction (HYPR). Magn Reson Med (2009) 1.02